Dr. Shahab Babakoohi, MD

Dr. Babakoohi practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Babakoohi's NPI, 1356606032, was assigned on July 9, 2012. Dr. Babakoohi holds North Carolina license 2020-02267.

Dr. Babakoohi's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Babakoohi's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Babakoohi is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Levine Cancer Institute. Dmand AI also links Dr. Babakoohi to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Babakoohi practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Babakoohi's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Babakoohi is licensed in North Carolina.

CMS data shows 1,063 Medicare services from Dr. Babakoohi across 9 procedure codes in 2024, for 234 Medicare patients. Medicare paid $34,538 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 234 Medicare patients who saw Dr. Babakoohi in 2024. The largest group is 65 to 74, with 115 patients. 70% of them have high blood pressure, and 70% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Babakoohi's median patient age at 73, with 45% women.

In 2024, Dr. Babakoohi wrote 375 Medicare Part D claims for 156 patients. 91% of them were for generic drugs. CMS names the drug for 300 of them, across 9 drugs with 11 or more claims each, at $52,856 in total drug cost. In 2023, CMS named 352 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Babakoohi for performance year 2024, reported as part of a group. Dr. Babakoohi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 334 procedures of removal of skin lesions by Dr. Babakoohi, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 23 papers to Dr. Babakoohi, published from 2011 to 2024. 2013 was the busiest year, with 3. The most frequent topics are Immunohistochemistry, Lung Neoplasms and Mouth Neoplasms. Dr. Babakoohi has published most often in Acta Odontol Scand. Dr. Babakoohi's most frequent co-authors are Afshin Dowlati, MD, Bardia Sadr, MD and Farzam Gorouhi, MD.

CMS Open Payments shows 31 general payments to Dr. Babakoohi from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,475.